Articles

Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors

Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France;Inserm U1170, Gustave Roussy, University Paris Sud, Equipe labellisée Ligue contre le Cancer 94805 Villejuif, France
Department of Haematology and National Health Service Blood & Transplant, Cambridge University, UK;MRC Biostatistics Unit, Cambridge, UK
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Post-Genomic Platform of Pitié-Salpêtrière (P3S), Pierre and Marie Curie University, F-75013 Paris, France
Post-Genomic Platform of Pitié-Salpêtrière (P3S), Pierre and Marie Curie University, F-75013 Paris, France
French Reference-Center on Inherited Platelet Disorders, Marseille, France
Assistance Publique-Hôpitaux de Paris, Hôpital Armand Trousseau, Paris, France
Department of Haematology and National Health Service Blood & Transplant, Cambridge University, UK;Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
French Reference-Center on Inherited Platelet Disorders, Marseille, France;Laboratoire d’hématologie, CHU de Bordeaux, Pessac, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France;French Reference-Center on Inherited Platelet Disorders, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France;French Reference-Center on Inherited Platelet Disorders, Marseille, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France
Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Germany
NIHR BioResource - Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, UK
LIRYC, Plateforme Technologique et d’Innovation Biomédicale, Hôpital Xavier Arnozan, Pessac, France
French Reference-Center on Inherited Platelet Disorders, Marseille, France;LIRYC, Plateforme Technologique et d’Innovation Biomédicale, Hôpital Xavier Arnozan, Pessac, France
Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Belgium
ICAN Institute of Cardiometabolism and Nutrition, F-75013 Paris, France;Inserm, UMR_S 1166, Team Genomics and Pathophysiology of Cardiovascular Diseases, F-75013 Paris, France;Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ Paris 06), UMR_S 1166, F-75013 Paris, France
Inserm U1170, Gustave Roussy, University Paris Sud, Equipe labellisée Ligue contre le Cancer 94805 Villejuif, France
Aix Marseille Univ, INSERM, INRA, NORT, Marseille, France;French Reference-Center on Inherited Platelet Disorders, Marseille, France
Vol. 102 No. 2 (2017): February, 2017 https://doi.org/10.3324/haematol.2016.147694